| San Diego Biotechnology Network

Eying “Extra” DNA As Cancer Driver, Boundless Bio Debuts With $46M

September 19, 2019 sandiegobiotech Comments Off

In the nucleus of human cells sit our chromosomes, comprised mainly of tightly wound DNA. In some cells, however, some pieces of genetic material that exist within the nucleus are not attached to a chromosome—and a new company, Boundless Bio, believes … […]

San Diego startup raises nearly $47 million for new approach to fighting cancer

September 19, 2019 sandiegobiotech Comments Off

Boundless Bio is targeting cancer-causing DNA found outside of chromosomes […]

Boundless Bio Launches to Deliver Transformative Therapies to Patients with Difficult-to-Treat Cancers Driven by Extrachromosomal DNA

September 19, 2019 sandiegobiotech Comments Off

SAN DIEGO–(BUSINESS WIRE)–Boundless Bio, a company interrogating and targeting ecDNA in aggressive cancers, announced the completion of a $46.4M Series A financing. […]

Artelo Biosciences Cannabidiol (CBD) Studies Referenced in September Issue of Nature Medicine

September 18, 2019 sandiegobiotech Comments Off

LA JOLLA, Calif., Sept. 18, 2019 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid system, announced today that two research studies condu… […]

Biotech Briefing: UC San Diego Health Uses 3D Technology to Fix Previously Inoperable Aortic Aneurysms

September 18, 2019 sandiegobiotech Comments Off

Reports + Research UC San Diego Health Uses 3D Technology to Fix Previously Inoperable Aortic Aneurysms A thoracoabdominal aortic aneurysm is an aneurysm that balloons out of the aorta, which causes aortic wall weakening. Traditionally, surgeons need t… […]

UC Irvine Spinout, Debut, Seeks to Transform Chemical Manufacturing Industry

September 18, 2019 sandiegobiotech Comments Off

SAN DIEGO, Sept. 18, 2019 /PRNewswire/ — Debut Biotechnology, a startup located in San Diego, California, has exclusively licensed two inventions from the University of California, Irvine (UCI) that will allow continuous manufacturing in the pharma… […]

News

Eying “Extra” DNA As Cancer Driver, Boundless Bio Debuts With $46M

San Diego startup raises nearly $47 million for new approach to fighting cancer

Boundless Bio Launches to Deliver Transformative Therapies to Patients with Difficult-to-Treat Cancers Driven by Extrachromosomal DNA

Artelo Biosciences Cannabidiol (CBD) Studies Referenced in September Issue of Nature Medicine

Biotech Briefing: UC San Diego Health Uses 3D Technology to Fix Previously Inoperable Aortic Aneurysms

UC Irvine Spinout, Debut, Seeks to Transform Chemical Manufacturing Industry

UC San Diego to create $100 million school of public health to fight disease, aging

Establishment of UC San Diego School of Public Health Approved

Supercomputer Simulations Help Optimize Floating Wind Farms

Acadia Pharmaceuticals plans $250 million stock offering